| 编号 |
论文标题 |
第一作者 |
通讯作者 |
统计师 |
来源项目 |
发表时间 |
发表杂志 |
影响因子 |
|
1770
|
Indobufen versus aspirin in patients with acute ischaemic stroke in China (INSURE): a randomised, double-blind, double-dummy, active control, non-inferiority trial
|
Yuesong Pan
Xia Meng
|
Yongjun Wang
|
金奥铭
|
OTHERS
|
2023-04-27
|
Lancet Neurology
|
59.935
|
|
1773
|
Colchicine in High-risk Patients with Acute Minor-to-moderate Ischemic Stroke or Transient Ischemic Attack (CHANCE-3): Rationale and design of a multicenter randomized placebo-controlled trial
|
Yongjun Wang
|
Yongjun Wang
|
王安心
|
OTHERS
|
2023-04-15
|
International Journal of Stroke
|
6.948
|
|
1541
|
Adherence to a healthy lifestyle and brain structural imaging markers
|
Yuesong Pan
Jie Shen
Xueli Cai
|
Changzheng Yuan
Yongjun Wang
|
金奥铭
|
PRECISE
|
2023-04-14
|
Eur J Epidemiol
|
12.434
|
|
1052
|
Atrial cardiopathy and the prognosis of ischemic stroke
|
Yueyang Wu
Xiaomeng Yang
|
Yongjun Wang
|
潘岳松
|
CNSR-Ⅲ
|
2023-03-08
|
Eur Stroke J
|
5.894
|
|
1415
|
Intravenous thrombolysis versus antiplatelet therapy in minor stroke patients with large vessel occlusion
|
Chunmiao Duan
Yunyun Xiong
|
Yongjun Wang
|
谷鸿秋
|
CNSR-Ⅲ
|
2023-03-07
|
CNS Neuroscience & Therapeutics
|
5.5
|
|
1656
|
High-Sensitivity C-Reactive Protein Modifies P-wave terminal force in lead V1-Associated Prognosis in Acute Ischemic Stroke or TIA Patients
|
Yueyang Wu
Wei Lv
|
Yongjun Wang
|
严鸿伊
|
CNSR-Ⅲ
|
2023-03-03
|
Journal of Clinical Medicine
|
4.96
|
|
1489
|
Prognostic Significance of Nonalcoholic fatty liver in Patients with Acute Ischemic Stroke: A large-scale nationwide, multicenter, prospective registry study
|
Keyang Chen
|
Xiaokun Li
Yongjun Wang
|
潘岳松
|
CNSR-Ⅲ
|
2023-02-28
|
Computers in Biology and Medicine
|
6.69
|
|
1505
|
the role of hsCRP in recurrent stroke differed between nondisabling and disabling cerebrovascular event
|
JIEJIE LI
|
YONGJUN WANG
|
潘岳松
|
CNSR-Ⅲ
|
2023-02-20
|
Journal of clinical medicine
|
4.96
|
|
1683
|
Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial
|
Yongjun Wang
|
Yongjun Wang
|
潘岳松
|
OTHERS
|
2023-02-09
|
The Lancet
|
202.731
|
|
1732
|
Trial of Endovascular Therapy for Acute Ischemic Stroke with Large Infarct
|
X. Huo
G. Ma
|
Z. Ren
Yongjun Wang
and Z. Miao
|
潘岳松
|
OTHERS
|
2023-02-09
|
The New England Journal of Medicine
|
176.079
|
